Blinatumomab as the first-line induction for ANCA-associated rapidly progressive glomerulonephritis.
- DOI
- 10.1136/rmdopen-2026-006790
- Published
- 2026 Sep 23
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2026-006790,
title = {Blinatumomab as the first-line induction for ANCA-associated rapidly progressive glomerulonephritis.},
author = {Wang J and Yu Y and Li R and Shi B and Wu W and Ding H and Du F and Ye S and Chen S},
year = {2026},
journal = {RMD open},
doi = {10.1136/rmdopen-2026-006790},
url = {https://doi.org/10.1136/rmdopen-2026-006790}
}RIS
TY - JOUR TI - Blinatumomab as the first-line induction for ANCA-associated rapidly progressive glomerulonephritis. AU - Wang J AU - Yu Y AU - Li R AU - Shi B AU - Wu W AU - Ding H AU - Du F AU - Ye S AU - Chen S PY - 2026 JO - RMD open DO - 10.1136/rmdopen-2026-006790 UR - https://doi.org/10.1136/rmdopen-2026-006790 ER -
APA
J, W., Y, Y., R, L., B, S., W, W., H, D., F, D., S, Y., & S, C. (2026). Blinatumomab as the first-line induction for ANCA-associated rapidly progressive glomerulonephritis.. RMD open. https://doi.org/10.1136/rmdopen-2026-006790